Compare · ITGR vs OM
ITGR vs OM
Side-by-side comparison of Integer Holdings Corporation (ITGR) and Outset Medical Inc. (OM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ITGR and OM operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- ITGR is the larger of the two at $3.24B, about 41.6x OM ($77.9M).
- Over the past year, ITGR is down 14.5% and OM is down 75.8% - ITGR leads by 61.3 points.
- ITGR has been more active in the news (5 items in the past 4 weeks vs 4 for OM).
- ITGR has more recent analyst coverage (23 ratings vs 13 for OM).
- Company
- Integer Holdings Corporation
- Outset Medical Inc.
- Price
- $95.31-4.40%
- $4.23-3.64%
- Market cap
- $3.24B
- $77.9M
- 1M return
- +4.58%
- -4.51%
- 1Y return
- -14.54%
- -75.81%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 5
- 4
- Recent ratings
- 23
- 13
Integer Holdings Corporation
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Outset Medical Inc.
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo Hemodialysis System, which comprises of a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Latest ITGR
- SEC Form 3 filed by new insider Metcalf Milo Stephen Ii
- SEC Form 4 filed by US - EVP, Operations Metcalf Milo Stephen Ii
- Integer Announces Conference Call to Discuss Second Quarter 2026 Results
- Chief Human Resources Officer Thor Kirk K converted options into 6,120 shares and covered exercise/tax liability with 2,409 shares, increasing direct ownership by 11% to 38,693 units (SEC Form 4)
- SEC Form 4 filed by President, Glob Ops & Manu Tec Harris John A
- Integer Holdings Corporation filed SEC Form 8-K: Leadership Update
- Integer to Participate in Truist Securities 2026 MedTech Conference on June 16
- Director Maxwell Martin C was granted 1,967 shares, increasing direct ownership by 9% to 25,106 units (SEC Form 4)
- SEC Form 4 filed by Director Hinrichs James F.
- Director Coyle Michael J was granted 1,967 shares, increasing direct ownership by 145% to 3,322 units (SEC Form 4)
Latest OM
- Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- General Counsel Brottem John L. was granted 59,830 shares, increasing direct ownership by 198% to 90,107 units (SEC Form 4)
- Chief Financial Officer Gaeta Renee was granted 71,630 shares, increasing direct ownership by 63% to 185,383 units (SEC Form 4)
- Chair and CEO Trigg Leslie was granted 99,160 shares, increasing direct ownership by 100% to 198,034 units (SEC Form 4)
- Outset Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Financial Statements and Exhibits
- Director Hackett Patrick T was granted 10,667 shares, increasing direct ownership by 11% to 105,839 units (SEC Form 4)
- Director Oboyle Kevin C was granted 10,667 shares, increasing direct ownership by 44% to 34,785 units (SEC Form 4)
- Director Prange Karen was granted 10,667 shares, increasing direct ownership by 57% to 29,334 units (SEC Form 4)
- Director Lang Brent D. was granted 10,667 shares, increasing direct ownership by 60% to 28,518 units (SEC Form 4)
- Director Grossman D Keith was granted 10,667 shares, increasing direct ownership by 77% to 24,585 units (SEC Form 4)